Bereits seit vielen Jahren stellen sich die Mitglieder des Evin Hub gemeinsam komplexen Forschungsfragen. Im Bereich Real-World Evidence können wir einen fundierten wissenschaftlichen Track Record zu verschiedenen Indikationen und Therapiefeldern vorweisen. Dieser belegt, dass wir nicht nur erfolgreich Forschung betreiben, sondern auch ein vertrauensvoller Ansprechpartner für viele namhafte Auftraggeber sind.
COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany. International journal of chronic obstructive pulmonary disease, 16, S. 2407–2417. DOI:https://doi.org/10.2147/COPD.S322036 (abgerufen am 02.11.2023).
Therapy areas: Respiratory
Indications: COPD
Correction: Real-world effectiveness of osteoporosis treatments in Germany. Archives of osteoporosis, 17, S. 129. DOI:https://doi.org/10.1007/s11657-022-01156-z (abgerufen am 30.10.2023).
Therapy areas: Bone
Indications: Osteoporosis
Corticosteroid Use in Patients With Systemic Lupus Erythematosus in Germany: The CHAMOMILE Claims Database Study. DGRh 2022, Berlin, Germany 31 August–3 September 2022. No DOI/URL available
Therapy areas: Immunology
Indications: Systemic Lupus Erythematosus
Costs and Complications of RSV in the Older Adult Population: A German Claims Database Analysis.16th dggö Annual Conference 2024, 04 March 2024, Halle, Germany No DOI/URL available RSV
Indications: Infectious Diseases
Cross Sectional Claims Data Analysis on Myopia Epidemiology and Treatment Options in Germany. Value in Health, Volume 26, Issue 11, S2 (December 2023). No DOI/URL available
Therapy areas: Ophthalmology
Indications: Myopia
Claims data analysis of health care resource use and costs of respiratory syncytial virus prevention in infants in Germany. [Vortrag]. ISPOR Europe 2023. ISPOR, 12.11.2023, Kopenhagen. Online: https://www.ispor.org/heor-resources/presentations-database/presentation/euro2023-3785/131531 (abgerufen am 03.01.2024).
Therapy areas: Infectious Diseases
Indications: RSV
Clinical and Economic Burden Among Patients With Prurigo Nodularis Compared To A Benchmark In Germany: A Real-World-Evidence Claims Data Study. ISPOR Europe 2022, 6 - 9 November 2022. No DOI/URL available
Therapy areas: Dermatology
Indications: Prurigo Nodularis
Clinical and Economic Burden of Hepatic and Extrahepatic Complications from Chronic Hepatitis C: A Retrospective Analysis of German Sickness Fund Data. Infect Dis Ther. 2018 Sep;7(3):327-338. doi: 10.1007/s40121-018-0204-3.
Therapy areas: Infectious Diseases
Indications: Hepatitis C
Clinical and economic burden of hypertrophic obstructive cardiomyopathy in Germany. DGK Herztage 29.09 – 01.10.2022. https://doi.org/10.1007/s00392-022-02087-y
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Cardiomyopathy
Clinical and economic burden of organ damage among patients with systemic lupus erythematosus in a real-world setting in Germany. BMC Rheumatol 8, 18 (2024). https://doi.org/10.1186/s41927-024-00387-6
Therapy areas: Immunology
Indications: Systemic Lupus Erythematosus
Clinical Characteristics, Health Care Resource Utilization, and Costs Associated With Flares in Patients With Systemic Lupus Erythematosus in Germany. Ann. Rheum. Dis. - EULAR 2022 Annual European Congress of Rheumatology, June 1–4, 2022. http://dx.doi.org/10.1136/annrheumdis-2022-eular.899
Therapy areas: Immunology
Indications: Systemic Lupus Erythematosus
CO65 Clinical and Economic Burden Among Patients With Prurigo Nodularis Compared to a Benchmark in Germany: A Real-World-Evidence Claims Data Study. Value in Health, 25(12), S. S30. DOI:<https://doi.org/10.1016/j.jval.2022.09.144> (abgerufen am 02.11.2023). No DOI/URL available
Therapy areas: Dermatology
Indications: Prurigo Nodularis
Characteristics, Treatment Patterns, and Clinical Outcomes of Chronic Hepatitis B Across 3 Continents: Retrospective Database Study. Adv Ther (Advances in Therapy), 40(2), S. 425–444. DOI:https://doi.org/10.1007/s12325-022-02284-1 (abgerufen am 17.11.2023).
Therapy areas: Infectious Diseases
Indications: Hepatitis B
Behandlungsmuster in einer polyartikulären juvenilen idiopathischen Arthritis-Population in Deutschland: eine retrospektive Beobachtungsstudie auf Basis von Krankenkassenabrechnungsdaten. RA.28. In: Deutsche Gesellschaft für Rheumatologie e. V. (Hrsg.). Deutscher Rheumatologiekongress 2023, 30.08–02.09.2023, Leipzig, S. 501. No DOI/URL available
Therapy areas: Immunology
Indications: Juvenile rheumatoid arthritis
Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study. EASD Congress 2019. No DOI/URL available
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Diabetes Type 2
Cardiorenal disease is the most common first CV manifestation in type 2 diabetes and associated with increased mortality: a large multinational observational study. European Association for the Study of Diabetes 55th Annual Meeting; 2019. No DOI/URL available
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Diabetes Type 2
Cardiorenal diseases are primary and life-threatening cardiovascular sequelae in type 2 diabetes patients: a secondary data analysis of the German BKK database Diabetologie & Stoffwechsel No DOI/URL available
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Diabetes Type 2
Cardiorenal Risk with SGLT2i versus DPP4i in T2D Patients without Established Cardiovascular- and Renal Diseases: A Large Multinational Observational Study ASN Congress No DOI/URL available
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Diabetes Type 2
Cardiorenal Risk with Sodium‐Glucose Cotransporter‐2 Inhibitors versus Dipeptidyl Peptidase‐4 Inhibitors in Type 2 Diabetes Patients without Cardiovascular and Renal Diseases: A large multinational observational study; Diabetes, Obesity and Metabolism, 2020 No DOI/URL available
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Diabetes Type 2
Case Fatality Risk and Attributable Costs in Patients Treated for Community-Acquired Pneumonia in Germany: A Population-Based Healthcare Claims Data Cohort Study. [preprint]. SSRN Electronic Journal. DOI:https://doi.org/10.2139/ssrn.4118607 (abgerufen am 30.10.2023).
Therapy areas: Respiratory
Indications: Pneumonia
Sie sehen gerade einen Platzhalterinhalt von Google Maps. Um auf den eigentlichen Inhalt zuzugreifen, klicken Sie auf die Schaltfläche unten. Bitte beachten Sie, dass dabei Daten an Drittanbieter weitergegeben werden.
Mehr Informationen